Robert Kramer, Emergent BioSolutions CEO

Emer­gent to cut over 130 po­si­tions to kick off new year

The Mary­land-based man­u­fac­tur­er Emer­gent BioSo­lu­tions is lay­ing off em­ploy­ees and two ex­ec­u­tives are de­part­ing.

In an an­nounce­ment on Mon­day, Emer­gent said that it will lay off 132 em­ploy­ees, as part of its plan to com­bine its re­search, prod­uct de­vel­op­ment, and clin­i­cal teams in­to a sin­gle “Sci­ence & De­vel­op­ment” team. The lay­offs amount to around 5% of Emer­gent’s cur­rent work­force. Ac­cord­ing to its an­nu­al re­port to the SEC for Fis­cal Year 2021, the man­u­fac­tur­er had 2,416 em­ploy­ees in to­tal. In a state­ment, Emer­gent CEO Robert Kramer said that the com­pa­ny will pro­vide re­sources to help all the em­ploy­ees af­fect­ed by the lay­offs, but no de­tails were pro­vid­ed.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.